Sunflower Pharmaceutical Group Co.,Ltd financials at a glance

The revenue of Sunflower Pharmaceutical Group Co.,Ltd is reported as 4.37141 billion Yuan Renminbi in the fiscal year 2019. The earnings were 0 Yuan Renminbi per share in 2019, which was 33.33 higher than 2017. And about 0.60709 billion Yuan Renminbi are reported as free cash flow in the financials of Sunflower Pharmaceutical Group Co.,Ltd 2019. Dividends of 1 Yuan Renminbi per share were paid to shareholders of Sunflower Pharmaceutical Group Co.,Ltd stock SZSE:002737 in fiscal 2019.